Gator SCALES-WHF: Lasix ONYU for Worsening Heart Failure
This study, called Gator SCALES-WHF, is testing a new way to treat worsening heart failure (when your heart can't pump enough blood) and fluid overload at home. It uses a medicine called Lasix ONYU, given under the skin (subcutaneous). Researchers want to see how safe Lasix ONYU is when used this way over 30 days. You might be able to join if you are 18 to 80 years old, have been diagnosed with heart failure, and have signs of fluid overload like high BNP levels, swelling in your legs, or recent weight gain. The study aims to enroll 100 participants, but its current status is unclear.
- Study design
- This is an open-label, non-comparative study, meaning both you and your doctors will know you are receiving Lasix ONYU. It aims to enroll 100 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your safety will be checked for 30 days after using Lasix ONYU.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure
At a glance
Conditions
NCT06979726
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Florida
Gainesville, Floridano site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Safety of Lasix ONYU Use30 days
Adverse reactions, acute kidney injury